Hirotaka Nakatomi - Hisamitsu Pharm Chairman

HTSUF -- USA Stock  

USD 38.50  0.00  0.00%

  Chairman
Mr. Hirotaka Nakatomi was serving as Chairman of the Board, Chief Executive Officer and Representative Director of Hisamitsu Pharmaceutical Co., Inc. since May 2015. He joined the Company in February 1966. His previous titles include Director of Medical Specialty, Managing Director and President in the Company.
Age: 80  Chairman Since 2015      
81 9 4283 2101  http://www.hisamitsu.co.jp

Management Efficiency

The company has return on total asset (ROA) of 4.43 % which means that it generated profit of $4.43 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 7.34 % meaning that it generated $7.34 on every $100 dollars invested by stockholders.
The company has accumulated 17.47M in total debt with debt to equity ratio (D/E) of 0.7 which is about average as compared to similar companies. Hisamitsu Pharm has Current Ratio of 5.99 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives

CHAIRMAN Since

Joseph PapaPerrigo Company plc
2015
Rodney PiattMylan NV
2011
Fang YaoSHANGHAI FOSUN PHARMACEUTICAL G
2016
Said DarwazahHikma Pharmaceuticals Plc
2018
Qiyu ChenSHANGHAI FOSUN PHARMACEUTICAL G
2016
Amir ElsteinTeva Pharmaceutical Industries
2014
Marry BrlasPerrigo Company plc
2016
Paul BisaroAllergan plc
2016
Brenton SaundersAllergan plc
2016
Chinh ChuCatalent
2014
Satish ReddyDr Reddys Laboratories Ltd
2014
G PrasadDr Reddys Laboratories Ltd
2014
Robert CouryMylan NV
2016
Qi ChenSHANGHAI FOSUN PHARMACEUTICAL G
2012
Mazen DarwazahHikma Pharmaceuticals Plc
2014

Entity Summary

Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. Hisamitsu Pharm operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 2792 people.Hisamitsu Pharm Ltd [HTSUF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Hisamitsu Pharm Leadership Team

Hirotaka Nakatomi, Chairman, CEO and Chairman of Crisis Management Committee
Hidenori Hadate, Senior Managing Executive Officer
Tsuyoshi Ayabe, Executive Officer, Manager of Corporate Strategy Office
Toshiaki Tsuruda, Executive Officer, Chief Director of Production Environment, Director
Toshihide Kanari, Executive Officer, Director of External Affairs, Manager of Public Relations Office
Teijiro Furukawa, Non-Executive Independent Director
Takeshi Shakata, Executive Officer, Director of Drug and Cosmetics Business
Akira Kawata, Executive Officer
Shinichiro Takao, General Manager of IR Department, Treasurer and Director
Nobuo Tsutsumi, Executive Officer, Director of Legal Affairs, Director
Hiroyuki Taketomi, Executive Officer, Senior Director of Manufacturing, Director of General Affairs in Tosu Plant, Tosu Plant Manager
Katsuhiko Akiyama, Executive Officer, Director of Development Planning, Director of Base Research Institute
Tetsuo Akiyama, Managing Director and Director
Takeshi Masumoto, Executive Officer, Director of Kinki Supervision Unit in Pharmaceutical Business Unit
Kazuhide Nakatomi, President, COO and Executive VP
Isao Ichikawa, Non-Executive Independent Director
Shinichi Murayama, Executive Officer, Manager of President's Office in Kyushu Headquarters, Director
Akira Kayashima, Executive Officer
Kyu Saito, Executive Officer, Director of International Business, Chairman of Subsidiaries, Director
Kiyotaka Takada, Executive Officer, Director of Production Technology Development
Hidenao Minami, Executive Officer, Director of Clinical Development
Takaaki Terahara, Executive Officer, Director of TDDS Research Institute, Manager of New Basic Technology Research Office, Manager of Patent Application Office
Naruhito Higo, Head of Research and Managing Director
Kotaro Sugimura, Executive Officer, Chief Director of Business, Manager of 1st Tokyo Office
Koji Takiyama, Executive Officer, Manager of President's Office
Kosuke Sugiyama, Senior Managing Director, Executive Officer, Director of Human Resource

Stock Performance Indicators

Did you try this?

Run Fundamentals Comparison Now

   

Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Module

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.
Search macroaxis.com